The inhibition of CCRK induced by bufalin reduced the activity of β-catenin/TCF signaling and subsequently suppressed the expression of CCND1 and EGFR, which impeded cell proliferation of PLC5 HCC cells. This evidence concerns the gene CCND1 and hepatocellular carcinoma.